Risk reduction of medication-related osteonecrosis of the jaw

N. Yarom; S. Fedele

doi:10.1007/978-3-662-43733-9_14

Risk reduction of medication-related osteonecrosis of the jaw

N. Yarom^*, S. Fedele

^*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Management of Medication-Related Osteonecrosis of the Jaw is challenging and outcomes of treatment are unpredictable. There is wide consensus that risk of ONJ can be, at least in part, reduced through control of a number of factors associated with increased likelihood of ONJ development. Robust evidence however remains limited. The aim of this chapter is to provide a comprehensive summary of available evidence upon riskreduction measures for patients at risk of ONJ.

Original language	English
Title of host publication	Medication-Related Osteonecrosis of the Jaws
Subtitle of host publication	Bisphosphonates, Denosumab, and New Agents
Publisher	Springer Berlin Heidelberg
Pages	149-153
Number of pages	5
ISBN (Electronic)	9783662437339
ISBN (Print)	9783662437322
DOIs	https://doi.org/10.1007/978-3-662-43733-9_14
State	Published - 1 Jan 2015
Externally published	Yes

Access to Document

10.1007/978-3-662-43733-9_14

Cite this

@inbook{c2c8913178904e699f64a46ad92582ec,

title = "Risk reduction of medication-related osteonecrosis of the jaw",

abstract = "Management of Medication-Related Osteonecrosis of the Jaw is challenging and outcomes of treatment are unpredictable. There is wide consensus that risk of ONJ can be, at least in part, reduced through control of a number of factors associated with increased likelihood of ONJ development. Robust evidence however remains limited. The aim of this chapter is to provide a comprehensive summary of available evidence upon riskreduction measures for patients at risk of ONJ.",

author = "N. Yarom and S. Fedele",

note = "Publisher Copyright: {\textcopyright} Springer-Verlag Berlin Heidelberg 2015.",

year = "2015",

month = jan,

day = "1",

doi = "10.1007/978-3-662-43733-9_14",

language = "אנגלית",

isbn = "9783662437322",

pages = "149--153",

booktitle = "Medication-Related Osteonecrosis of the Jaws",

publisher = "Springer Berlin Heidelberg",

}

TY - CHAP

T1 - Risk reduction of medication-related osteonecrosis of the jaw

AU - Yarom, N.

AU - Fedele, S.

N1 - Publisher Copyright: © Springer-Verlag Berlin Heidelberg 2015.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Management of Medication-Related Osteonecrosis of the Jaw is challenging and outcomes of treatment are unpredictable. There is wide consensus that risk of ONJ can be, at least in part, reduced through control of a number of factors associated with increased likelihood of ONJ development. Robust evidence however remains limited. The aim of this chapter is to provide a comprehensive summary of available evidence upon riskreduction measures for patients at risk of ONJ.

AB - Management of Medication-Related Osteonecrosis of the Jaw is challenging and outcomes of treatment are unpredictable. There is wide consensus that risk of ONJ can be, at least in part, reduced through control of a number of factors associated with increased likelihood of ONJ development. Robust evidence however remains limited. The aim of this chapter is to provide a comprehensive summary of available evidence upon riskreduction measures for patients at risk of ONJ.

UR - http://www.scopus.com/inward/record.url?scp=84956766322&partnerID=8YFLogxK

U2 - 10.1007/978-3-662-43733-9_14

DO - 10.1007/978-3-662-43733-9_14

M3 - פרק

AN - SCOPUS:84956766322

SN - 9783662437322

SP - 149

EP - 153

BT - Medication-Related Osteonecrosis of the Jaws

PB - Springer Berlin Heidelberg

ER -

Risk reduction of medication-related osteonecrosis of the jaw

Abstract

Access to Document

Other files and links

Fingerprint

Cite this